Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors

References

• Blay J-Y, Kang Y-K, Nishida T, et al. Gastrointestinal stromal tumours. Nat Rev Dis Primers. 2021;7(1):22. doi: 10.1038/s41572-021-00254-5.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zheng R, Zhang S, et al. Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China. Cancer Biol Med. 2019;16(3):565–574. doi: 10.20892/j.issn.2095-3941.2019.0041.
   PubMed Web of Science ®Google Scholar
• von Mehren M, Kane JM, Riedel RF, et al. NCCN guidelines® insights: gastrointestinal stromal tumors, version 2.2022. J Natl Compr Canc Netw. 2022;20(11):1204–1214. doi: 10.6004/jnccn.2022.0058.
   PubMed Web of Science ®Google Scholar
• Antonescu CR, DeMatteo RP. CCR 20th anniversary commentary: a genetic mechanism of imatinib resistance in gastrointestinal stromal tumor-Where are We a decade later? Clin Cancer Res. 2015;21(15):3363–3365. doi: 10.1158/1078-0432.CCR-14-3120.
   PubMed Web of Science ®Google Scholar
• Fernández JÁ, Alconchel F, Gómez B, et al. Unresectable GIST liver metastases and liver transplantation: a review and theoretical basis for a new indication. Int J Surg. 2021;94:106126. doi: 10.1016/j.ijsu.2021.106126.
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Vauthey J-N, Abdalla EK, et al. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg. 2006;141(6):537–543. discussion 543-544. doi: 10.1001/archsurg.141.6.537.
   PubMedGoogle Scholar
• Izzo F, Granata V, Grassi R, et al. Radiofrequency ablation and microwave ablation in liver tumors: an update. Oncologist. 2019;24(10):e990–e1005. doi: 10.1634/theoncologist.2018-0337.
   PubMed Web of Science ®Google Scholar
• Du Y-Q, Bai X-M, Yang W, et al. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinoma. Int J Hyperthermia. 2022;39(1):517–524. doi: 10.1080/02656736.2022.2048907.
   PubMed Web of Science ®Google Scholar
• Bai X-M, Yang W, Zhang Z-Y, et al. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer. Int J Hyperthermia. 2019;35(1):183–193. doi: 10.1080/02656736.2018.1488279.
   PubMed Web of Science ®Google Scholar
• Yang W, Yan K, Wu G-X, et al. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: strategies and long-term outcomes. World J Gastroenterol. 2015;21(5):1554–1566. doi: 10.3748/wjg.v21.i5.1554.
   PubMed Web of Science ®Google Scholar
• Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301(3):533–540. doi: 10.1148/radiol.2021203715.
   PubMed Web of Science ®Google Scholar
• Sacks D, McClenny TE, Cardella JF, et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199–S202. doi: 10.1097/01.rvi.0000094584.83406.3e.
   PubMed Web of Science ®Google Scholar
• Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the international study group of liver surgery. Surgery. 2011;149(5):680–688. doi: 10.1016/j.surg.2010.12.002.
   PubMed Web of Science ®Google Scholar
• Chen Q, Li C, Yang H, et al. Resection combined with TKI therapy for resectable liver metastases of gastrointestinal stromal tumours: results from three national centres in China. J Gastrointest Surg. 2020;24(6):1330–1341. doi: 10.1007/s11605-019-04278-x.
   PubMed Web of Science ®Google Scholar
• Jung J-H, Won HJ, Shin YM, et al. Safety and efficacy of radiofrequency ablation for hepatic metastases from gastrointestinal stromal tumor. J Vasc Interv Radiol. 2015;26(12):1797–1802. doi: 10.1016/j.jvir.2015.09.002.
   PubMed Web of Science ®Google Scholar
• Chen Q, Li C, Yang H, et al. Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: results from three national centres in China. Clin Res Hepatol Gastroenterol. 2019;43(3):317–323. doi: 10.1016/j.clinre.2018.10.012.
   PubMed Web of Science ®Google Scholar
• Yamanaka T, Takaki H, Nakatsuka A, et al. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor. J Vasc Interv Radiol. 2013;24(3):341–346. doi: 10.1016/j.jvir.2012.11.021.
   PubMed Web of Science ®Google Scholar
• Hakimé A, Le Cesne A, Deschamps F, et al. A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors. Cardiovasc Intervent Radiol. 2014;37(1):132–139. doi: 10.1007/s00270-013-0615-1.
   PubMed Web of Science ®Google Scholar
• Jones RL, McCall J, Adam A, et al. Radiofrequency ablation is a feasible therapeutic option in the multi-modality management of sarcoma. Eur J Surg Oncol. 2010;36(5):477–482. doi: 10.1016/j.ejso.2009.12.005.
   PubMed Web of Science ®Google Scholar
• Yoon IS, Shin JH, Han K, et al. Ultrasound-Guided intraoperative radiofrequency ablation and surgical resection for liver metastasis from malignant gastrointestinal stromal tumors. Korean J Radiol. 2018;19(1):54–62. doi: 10.3348/kjr.2018.19.1.54.
   PubMed Web of Science ®Google Scholar
• Patterson T, Li H, Chai J, et al. Locoregional treatments for metastatic gastrointestinal stromal tumor in British Columbia: a retrospective cohort study from january 2008 to december 2017. Cancers. 2022;14(6):1477. doi: 10.3390/cancers14061477.
   PubMed Web of Science ®Google Scholar
• Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009;19(5):1206–1213. doi: 10.1007/s00330-008-1258-5.
   PubMed Web of Science ®Google Scholar
• Zhang Z-Y, Jiang A-N, Yang W, et al. Percutaneous radiofrequency ablation is an effective method for local control of liver metastases from lung cancer. Front Oncol. 2022;12:877273. doi: 10.3389/fonc.2022.877273.
   PubMed Web of Science ®Google Scholar
• Fernández JÁ, Gómez-Ruiz ÁJ, Olivares V, et al. Clinical and pathological features of “small” GIST (≤2 cm). what is their prognostic value? Eur J Surg Oncol. 2018;44(5):580–586. doi: 10.1016/j.ejso.2018.01.087.
   PubMed Web of Science ®Google Scholar
• Casali PG, Blay JY, Abecassis N, et al. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(1):20–33. doi: 10.1016/j.annonc.2021.09.005.
   PubMed Web of Science ®Google Scholar
• Blay J-Y, Shen L, Kang Y-K, et al. Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial. Lancet Oncol. 2015;16(5):550–560. doi: 10.1016/S1470-2045(15)70105-1.
   PubMed Web of Science ®Google Scholar
• Bauer S, Rutkowski P, Hohenberger P, et al. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib – analysis of prognostic factors (EORTC-STBSG collaborative study). Eur J Surg Oncol. 2014;40(4):412–419. doi: 10.1016/j.ejso.2013.12.020.
   PubMed Web of Science ®Google Scholar
• Choi H. Response evaluation of gastrointestinal stromal tumors. Oncologist. 2008;13 Suppl 2(S2):4–7. doi: 10.1634/theoncologist.13-S2-4.
   PubMedGoogle Scholar
• Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol. 2009;6(6):339–351. doi: 10.1038/nrclinonc.2009.44.
   PubMed Web of Science ®Google Scholar
• Suh SW, Choi YS. Predictors of micrometastases in patients with barcelona clinic liver cancer classification B hepatocellular carcinoma. Yonsei Med J. 2017;58(4):737–742. doi: 10.3349/ymj.2017.58.4.737.
   PubMed Web of Science ®Google Scholar
• Sutton TL, Walker BS, Billingsley KG, et al. Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone. HPB . 2022;24(6):986–993. doi: 10.1016/j.hpb.2021.11.011.
   PubMed Web of Science ®Google Scholar
• Xiao B, Peng J, Tang J, et al. Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: a retrospective study from a single center. Cancer Manag Res. 2018;10:6121–6127. doi: 10.2147/CMAR.S187061.
   PubMed Web of Science ®Google Scholar
• Kelly CM, Gutierrez Sainz L, Chi P. The management of metastatic GIST: current standard and investigational therapeutics. J Hematol Oncol. 2021;14(1):2. doi: 10.1186/s13045-020-01026-6.
   PubMed Web of Science ®Google Scholar